Sinovac Biotech (SVA) shareholder Heng Ren Partners, LLC funds sent an open letter to Sinovac’s shareholders outlining the ...

Specifically, Heng Ren demands that Sinovac’s Board of Directors announce a distribution of $8.9B in cash to its shareholders and cause the resumption of trading of the company’s shares.

2. Reinstate Trading . After announcing a plan to distribute cash to shareholders, the Company must take all action necessary to cause the resumption of trading of Sinovac's shares on NASDAQ. The ...

Like you, we are shareholders in Sinovac Biotech Ltd. ("Sinovac" or the "Company"). Heng Ren Partners, LLC ("Heng Ren") manages funds that have held Sinovac shares since 2018. Heng Ren has long ...

Specifically, Heng Ren demands that Sinovac's Board of Directors announce a distribution of $8.9 billion in cash to its shareholders and cause the resumption of trading of the Company's shares.